NEET SS 2024 DrNB Gynaecological Oncology Paper 3 Question Paper with Solutions PDF is available for download. NEET SS 2024 exam is conducted by the National Board of Examinations in Medical Sciences (NBEMS). NEET SS 2024 question paper consists of 10 questions to be attempted in 3 hours. The paper is divided into broad-specialty topics (40%) and super-specialty topics (60%).
You can download NEET SS 2024 question paper with answer key and solutions PDF using the links given below.
NEET SS 2024 DrNB Gynaecological Oncology Paper 3 Question Paper with Solutions
| NEET SS 2024 DrNB Gynaecological Oncology Paper 3 Question Paper |  Download |
Check Solutions |
Explain the different types of fractionation regimens with clinical application of each.
Describe the mechanism of action of radiation sensitizers with an applied example.
Briefly describe the advantages of image guided adaptive brachytherapy over the traditional 2D film-based brachytherapy.
Mechanism of action of taxane.
Describe various routes and dosing schedules for paclitaxel in gynecological cancers.
Describe common toxicities of taxane agents and how to prevent and treat them.
Evidence for immunotherapy in cervical cancer.
How will you select a patient of cervical cancer for immunotherapy?
Role of anti-angiogenic agents in cervical cancer.
Describe key clinical trials of maintenance PARP inhibitor therapy in ovarian cancer in primary setting.
Describe evidence for use of PARP inhibitor in the management of patient with BRCAwt/HRD positive with recurrent high grade serous ovarian cancer.
What are the common toxicities of PARPi and how to manage them?
Describe the role of palliative surgeries in the management of gynecological cancer patients.
What is end of life care?
Phases of clinical trial.
What is a crossover trial design? Explain with an example.
Define case control study and cohort study.
P value and level of significance.
Types of errors and power of study.
Odds ratio and relative risk.
Discuss the factors influencing the biological effect of a given dose of radiation.
Describe late toxicities of radiotherapy for cervical cancer and their management.
Discuss evidence for and advantages of IMRT in adjuvant setting.
Uterine sarcoma:
Immunohistochemical (IHC) and molecular profiles of leiomyosarcoma and endometrial stromal sarcoma.
Uterine sarcoma:
Indications for adjuvant chemotherapy and various chemotherapy protocols.
Uterine sarcoma:
Role of hormonal therapy.
How socio-cultural factors may influence palliative care?
Benefits of Hospice care.
What are the various challenges faced by caregivers of gynecological cancer patients?
Comments